Abstract:PI3K is a kind of lipid kinase, controlling the cell growth, proliferation, migration, survival, angiogenesis and by activating PI3K, and AKT and mTOR to promote the development of tumor. mTOR for mammals rapamycin tar-gets is a serine/threonine protein kinase, which is widely expressed in the cell, is a kind of targeted target for the treat-ment of cancer. This paper mainly shows PI3K cancer cell line-the change of the mTOR signaling pathways, including the mechanism of action of breast cancer, prostate cancer, lung cancer, pancreatic cancer, liver cancer, etc.. PI3K-mTOR is promising targeting tumor treatment goals. Multiple targets for inhibiting tumor is the most effective method of treatment, by discussing research in clinical trials of PI3K-mTOR inhibitor drugs, for the future clinical antitumor drug research and development to provide a new way.

Research new progress on inhibitors antitumor of PI3K-mTOR signaling pathway